ClinicalTrials.gg
CompletedNCT02429947Updated Jun 14, 2017

An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients

An observational study in Charcot Marie Tooth Disease (CMT), Hereditary Sensory and Motor Neuropathy and Nerve Compression Syndromes, sponsored by University of South Florida. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-06-14.

Sponsored by University of South Florida · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
411
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to identify the issues that have greatest impact on QOL for patients with Charcot Marie Tooth (CMT) Disease. Patients who have -registered in the Inherited Neuropathies Consortium Contact Registry will be invited to participate.

Read the detailed description

The protocol consists of two anonymous surveys. The first large scale survey is designed to identify items that best reflect the issues and symptoms with high impact upon QOL in CMT. A second brief survey focuses on the frequency and impact of muscle cramps on QOL in adult CMT. The surveys will be distributed via an online link to all adult CMT patients self-registered with the RDCRN contact registry. Those who complete the first two surveys will be requested to complete only the second brief survey on muscle cramps again 3 weeks after completing it the first time. Those who complete the brief muscle cramps survey a second time will be requested to complete it again 5 weeks later to assess variability in occurrence of muscle cramps.

The first large scale survey to identify items that best reflect the issues and symptoms with high impact upon QOL in CMT will be sent out in a second wave. This second wave will only contain the QOL survey and not the muscle cramp survey. The QOL survey will be distributed via an online link to three populations: adult CMT patients self-registered with the INC (RDCRN) Contact Registry who had not been registered at the time of the first enrollment period, adult patients who had been registered at the time of the first enrollment period and had received the survey, but had not returned it, and patients who were registered, but were under age 18 at the time of the first enrollment period and have turned 18 by the time of the second enrollment period.

02

Conditions studied

  • Charcot Marie Tooth Disease (CMT)
  • Hereditary Sensory and Motor Neuropathy
  • Nerve Compression Syndromes
  • Tooth Diseases
  • Congenital Abnormalities
  • Genetic Diseases, Inborn
  • Heredodegenerative Disorders, Nervous System

Keywords

  • Charcot Marie Tooth disease
  • CMT
  • HMSN
  • HMN
  • HSN
03

In context

Charcot-Marie-Tooth Disease

130 studies on the registry are indexed under Charcot-Marie-Tooth Disease; 38 are open to participants now.

This study's enrollment of 411 is above the median of 92 across 52 observational studies indexed under Charcot-Marie-Tooth Disease.

Browse Charcot-Marie-Tooth Disease studies →

Lead sponsor

University of South Florida is the lead sponsor of 338 studies on the registry; 63 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with CMT, 18 years or older, who have joined the Inherited Neuropathies Consortium RDCRN Contact Registry.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with CMT that are 18 years or older and have joined the INC RDCRN Contact Registry.

Exclusion criteria

Exclusion Criteria:

  • Does not have CMT.
  • Does not read or speak English.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
411 participants (actual)
Patient registry
No

Groups and cohorts

  • INC Contact Registry Participants

    Adult CMT patients who have self-registered at the Inherited Neuropathies Consortium (INC) Contact Registry, a web-based contact registry developed and supported by the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Consortium (RDCRN), located at the University of South Florida.

06

What researchers measure

Primary outcomes

  1. Percentage of participants affected by specific symptoms of CMT.

    The percentage of subjects within the sample who have reported experience with the symptom will be calculated.

    Time frame: 1 year

Secondary outcomes

  1. Severity of impact of each identified symptom of CMT

    The symptoms will be rank ordered with symptoms that affect life severely receiving the highest rank.

    Time frame: 1 year

07

Study locations

1 site
  • RDCRN Data Management and Coordinating Center , Epidemiology Center; University of South Florida
    Tampa, Florida 33612, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 14, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02429947
Responsible party
Sponsor
First posted
Apr 29, 2015
Start date
Jul 2012
Primary completion
Jun 2013
Completion
Jun 2013
Last update
Jun 14, 2017

Study contacts

David Herrmann, MBBCh
study chair · University of Rochester

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion